Table 1.
Patient demographics in the introductory phase
| Introductory phase | p Value | ||
|---|---|---|---|
| ZF (n = 16) | FL (n = 16) | ||
| Age, years | 57.9 ± 2.8 | 59.4 ± 1.8 | 0.647 |
| Female gender | 5 (31.3%) | 2 (12.5%) | |
| BMI, kg/m2 | 28.6 ± 1.0 | 28.5 ± 1.3 | 0.969 |
| Hypertension | 11 (68.8%) | 9 (56.3%) | 0.716 |
| Diabetes mellitus | 1 (6.3%) | 4 (25%) | 0.333 |
| Coronary artery disease | 1 (6.3%) | 5 (31.3%) | 0.172 |
| Prior stroke/TIA | 0 | 0 | |
| Persistent atrial fibrillation | 3 (18.8.25%) | 4 (25.0%) | 1.000 |
| EHRA classification | |||
| 1 | 0 | 0 | |
| 2 | 13 (81.3%) | 11 (68.8%) | 0.343 |
| 3 | 3 (18.3%) | 5 (31.3%) | 0.343 |
| 4 | 0 | 0 | |
| Sinus rhythm at baseline | 13 (81.3) | 9 (56.3%) | 0.252 |
| LA diameter (mm) | 41.2 ± 2.2 | 45.13 ± 2.2 | 0.211 |
ZF zero-fluoroscopic group, FL fluoroscopic group, TIA transient ischemic attack. Values are mean ± SEM and absolute numbers